Showing results (221-230 of 230) with videos related to
Sort By:
Pageof 23
You have reached the last page of results.This site can display upto 230 results.
European Annals of Otorhinolaryngology, Head and Neck Diseases|December 22, 2023
Laryngeal graft after total laryngectomy in humans: A SWiM analysisP Céruse, S Vergez, J-P Marie, et al.Leukemia|July 14, 2006
Imatinib and methylprednisolone alternated with chemotherapy improve the outcome of elderly patients with Philadelphia-positive acute lymphoblastic leukemia: results of the GRAALL AFR09 studyA Delannoy, E Delabesse, V Lhéritier, et al.Leukemia|January 20, 2009
Fully functional NK cells after unrelated cord blood transplantationV Beziat, S Nguyen, S Lapusan, et al.Leukemia|August 5, 2005
Gemtuzumab ozogamicin (Mylotarg) as single-agent treatment for frail patients 61 years of age and older with acute myeloid leukemia: final results of AML-15B, a phase 2 study of the European Organisation for Research and Treatment of Cancer and Gruppo Italiano Malattie Ematologiche dell'Adulto Leukemia GroupsS Amadori, S Suciu, R Stasi, et al.Leukemia|August 26, 2006
Non-infusional vs intravenous consolidation chemotherapy in elderly patients with acute myeloid leukemia: final results of the EORTC-GIMEMA AML-13 randomized phase III trialU Jehn, S Suciu, X Thomas, et al.Bone Marrow Transplantation|November 18, 2014
High numbers of mobilized CD34+ cells collected in AML in first remission are associated with high relapse risk irrespective of treatment with autologous peripheral blood SCT or autologous BMTM Hengeveld, S Suciu, Y Chelgoum, et al.Leukemia|August 18, 1999
Granulocyte-macrophage colony-stimulating factor (GM-CSF) to increase efficacy of intensive sequential chemotherapy with etoposide, mitoxantrone and cytarabine (EMA) in previously treated acute myeloid leukemia: a multicenter randomized placebo-controlled trial (EMA91 Trial)X Thomas, P Fenaux, H Dombret, et al.International Journal of Pediatric Otorhinolaryngology|June 19, 2023
Audiological phenotyping evaluation in KBG syndrome: Description of a multicenter reviewL Rhamati, A Marcolla, A M Guerrot, et al.Leukemia|July 1, 1997
Multicentric evaluation of the MDR phenotype in leukemia. French Network of the Drug Resistance Intergroup, and Drug Resistance Network of Assistance Publique-Hôpitaux de ParisJ P Marie, S Huet, A M Faussat, et al.Leukemia|July 1, 1997
French multicentric evaluation of mdr1 gene expression by RT-PCR in leukemia and solid tumours. Standardization of RT-PCR and preliminary comparisons between RT-PCR and immunohistochemistry in solid tumours. French Network of the Drug Resistance Intergroup, and Drug Resistance Network of Assistance Publique-Hôpitaux de ParisS Chevillard, P Vielh, P Validire, et al.Pageof 23